Prototype Web Portal Shows Technology’s Potential to Protect and Streamline the Clinical Trials Process
UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results—such as making the treatment look more effective or diminishing side effects.
“Everyone is talking about how blockchain is going to revolutionize many of the data challenges in medicine, and here is one use that finally might make sense,” said Atul Butte, MD, PhD, who is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF. “We think it could someday be useful for pharma companies running clinical trials.”
The research was published February 22 in Nature Communications.
Blockchain technology utilizes an old computer science technique known as hashing, which creates a unique digital signature for each so-called block of data. The hashes accumulate sequentially, as new data is entered or changed, with each block depending on the last. The resulting “blockchain” creates an audit trail for regulators that is easy to decipher and validate, even without looking at the actual data.
Daniel Wong, a PhD candidate in Biological and Medical Informatics at UCSF, built the system to operate through a web portal, so that each time new data is entered on a given trial participant, the sender, receiver, timestamp, and file attachment containing the data, along with the hash of the previous block of data pertaining to that patient, is recorded onto a new block, with its own distinct signature.
Unlike the decentralized nature of most blockchain applications, this clinical trial prototype depends on having a regulator with centralized authority, such as the U.S. Food and Drug Administration, to operate the web portal, register all parties, and keep a ledger of the blockchain’s hashes.
Data, including adverse events, would be reported to the regulatory agency in real time, which may provide a boost to the safety and efficiency of clinical trials. While the prototype makes allowances for data entry or other errors to be corrected, new data can only be appended to the existing chain, without erasing what was there before.
“It makes it really obvious when someone’s changing something,” Wong said. “You can see who put their hands on it, who made it, who changed it, and who received it.”
Wong tested the system with a small subset of data from a real, previously run phase II trial included in ImmPort, a repository of open clinical trial data funded by the National Institutes of Allergy and Infectious Diseases (NIAID) that is managed by Butte’s lab and collaborators.
After entering the original data, he logged in as the trial sponsor and tried to erase adverse events that had been reported for two patients in their case report forms. Instead of deleting those reports, however, the system appended his changes to the original data, making it clear who had tried to corrupt the forms, when it was done, and what had been changed.
Wong also tried corrupting the data stored from an earlier point in the trial, when patients were assigned to different treatment arms—drug or placebo—to make it look as though they had been given a different medication plan. But the blockchain ledger pinpointed exactly what had changed and when.
A prototype system like this reduces risks, but does not completely protect data from tampering. Even within a system enabled with this type of blockchain technology, the authors pointed out, it is still possible that those seeing patients at the point of care could enter wrong or incorrect data at the outset.
But blockchain technology could enable trials to be conducted under challenging conditions, or open doors to data exchanges that are more secure, more efficient, and more transparent for both researchers and the general public.
“A system built upon our prototype could be developed to enable oversight of international clinical trials, for example,” Butte said. “And it could be expanded to provide more access to raw data for research scientists, the way we do with ImmPort, or deliver trial results to the public.”
The Latest on: Blockchain
via Google News
The Latest on: Blockchain
- Blockchain/IoT integration accelerates, hits a 'sweet spot' for the two technologieson December 11, 2019 at 3:04 am
Three-quarters of companies implementing IoT have already adopted blockchain or plan to use it by the end of 2020, an indicator of the growing connection between the two, according to a survey of 500 ...
- Automotive Blockchain Market to Garner $5.6 Bn, Globally, by 2030 at 29.3% CAGR, Says Allied Market Researchon December 11, 2019 at 2:00 am
Reduced operational cost and protection against data leak and manipulations drive the growth of the global automotive blockchain market PORTLAND, Oregon, Dec. 11, 2019 /PRNewswire/ -- Allied Market ...
- Blockchain Market : Industry Outlook By Drivers, Restraints And 2019-2025on December 11, 2019 at 1:41 am
Dec 11, 2019 (AmericaNewsHour) -- Global Blockchain Market was valued at USD 357.8 Million in the year 2017. Global Blockchain Market is further estimated to grow at a CAGR of 74.4% from 2019 to reach ...
- Blockchain Revolution: 80 Japanese Banks Join JP Morgan IINon December 10, 2019 at 9:48 pm
80 Japanese banks to join JP Morgan's blockchain network to improve anti-money laundering measures IIN already has 365 banks that have formally signed a letter of intent to join Blockchain is ...
- Russia’s Power Grid Company Tests Blockchain for Power Meter Dataon December 10, 2019 at 3:54 pm
Russia’s national power grid company Rosseti is testing a system for electricity bill payments based on a distributed ledger by Waves. Waves Enterprise, the enterprise blockchain arm of the Russian ...
- Improving International Trade With Blockchainon December 10, 2019 at 1:01 pm
This allows us to drive transformation in international trade. To do this, we are partnering with Amazon Web Services (AWS) to leverage their Amazon Managed Blockchain platform. There's ample reason ...
- Selling Blockchain To Enterprises: How Ripple And Others Make Moneyon December 10, 2019 at 11:46 am
The blockchain technology that appeared in 2008 with the introduction of Bitcoin is developing approximately five times as quickly as the Internet did. It even went through its boom and bust periods ...
- Santander Exec Claims Blockchain Success as Bank Redeems Ethereum-Issued Bondon December 10, 2019 at 4:53 am
Spanish banking multinational Santander has redeemed a bond worth $20 million that it issued on the public ethereum blockchain in September. With the move, John Whelan, head of Digital Investment ...
- Blockchain Adds to Swiss Money Laundering Risks, Finma Warnson December 10, 2019 at 2:18 am
Switzerland’s financial regulator warned the nation is “particularly exposed” to money laundering risks given its traditional role as a magnet for the world’s wealthy as well as emerging threats from ...
- A blockchain firm advised by Nobel laureate Myron Scholes just launched a rival to Facebook's libraon December 10, 2019 at 2:01 am
But the firm doesn't plan to launch its token in the U.S. yet, claiming it doesn’t currently have the regulatory clarity required to do so. One blockchain company thinks it has an alternative to ...
via Bing News